ASAP Live - Diabetes 1-Diabetes 1 Video

Video Transcription

Video Summary

This video summary touched on several medical cases. In the first case, a patient with type 2 diabetes and heart failure was discussed. The recommended next step for this patient was to discontinue the current medication and start an SGLT2 inhibitor to improve heart failure outcomes. In the second case, a patient with type 1 diabetes experienced hypoglycemia. The recommended next step was to switch the basal insulin from glargine to degladec to reduce the risk of nocturnal hypoglycemia. In the third case, a patient with type 2 diabetes and sickle cell trait had abnormal lab results, including a high A1C. It was determined that the A1C result was accurate and appropriate lifestyle interventions and possibly metformin were recommended. In the fourth case, a patient with type 2 diabetes and weight gain was advised to add a once-weekly GLP-1 receptor agonist to their treatment regimen. The mechanism of action for GLP-1 receptor agonists was discussed, with the correct option being stimulation of glucose-dependent insulin release. In the fifth case, a patient with type 1 diabetes developed lipo-atrophy, a complication of insulin therapy. This was determined to be an immune-mediated inflammatory reaction to insulin. In the sixth case, a patient with sepsis and cholecystitis received IV insulin support. The expected outcome of improving glycemic control in this patient was a reduction in overall mortality. Overall, the video covered various medical cases and provided recommendations for appropriate treatment and management.

Keywords

type 2 diabetes

heart failure

SGLT2 inhibitor

type 1 diabetes

hypoglycemia

basal insulin

glargine

degladec

sickle cell trait

A1C